{"schema_version":1,"assessment_id":"eoa_inverse_innovation_exp03_opportunity320_20260801","source_experiment_id":"eoa_inverse_innovation_exp03_full320_20260801","cell_id":"deadweight_loss_reduction__innovation_entrepreneurship","archetype_slug":"deadweight_loss_reduction","domain_slug":"innovation_entrepreneurship","title":"Risk-Tiered Approval for Bounded Startup Experiments","opportunity_summary":"Create a separately authorized experimental tier for small, reversible startup tests that uses isolated environments, minimized or synthetic data, logged access, named owners, explicit exclusions, expiry, and mandatory production re-review. The proposal could generate decision-relevant learning with less approval burden, but the sealed record does not establish that production-grade controls are a material cause of abandonment or that this composition is distinctive.","adopter_authorizer":"A target organization’s formally delegated business-unit, procurement, security, privacy, legal, and compliance owners acting jointly; regulators, contractual duties, and affected-party rights remain controlling.","scores":{"meaningful_impact":{"score":4,"rationale":"If the asserted approval wedge is material, enabling otherwise-abandoned experiments to produce usable evidence could improve both organizational adoption decisions and startup validation opportunities. The scale and prevalence of the blocked surplus are unverified."},"stakeholder_pull":{"score":3,"rationale":"Startups and innovation sponsors have a stated incentive to reduce delay, while reviewers may value clearer proportional controls. No demonstrated demand, sponsor commitment, reviewer support, or affected-party acceptance is present."},"incremental_advantage":{"score":4,"rationale":"Relative to the ordinary production pathway and sponsor-dependent exceptions, the proposal offers an explicit risk tier, preset safeguards, expiry, rollback, and retained production review. Whether these changes outperform well-run case-by-case exceptions is untested."},"distinctiveness_plausibility":{"score":2,"rationale":"The particular composition is coherent, but prior art is explicitly unsearched and the packet provides no basis for distinguishing it from enterprise sandboxes, procurement fast tracks, or risk-tiered vendor pilots."},"technical_implementability":{"score":4,"rationale":"The intervention relies mainly on implementable process and environment controls: isolation, minimized or synthetic data, scoped credentials, logging, named ownership, and re-review. Feasibility falls if target experiments cannot be meaningfully isolated from production-like privacy, security, reputational, or decision harms."},"adoption_authority_feasibility":{"score":3,"rationale":"Relevant authorizers and their bounded authority are identified, but approval is distributed across several functions whose incentives, delegation rules, and willingness to accept an experimental tier are unknown."},"evidence_readiness":{"score":4,"rationale":"The proposal specifies observable outcomes, confounders, comparison cases, intervention falsifiers, safety thresholds, equity measures, reviewer load, and evidence-quality criteria. Comparable-case availability and reliable historical process data remain uncertain."},"safety_net_benefit":{"score":4,"rationale":"Isolation, data minimization, prohibited uses, incident halts, admission pauses, reversion, expiry, and full production re-review provide multiple protections against scope creep and misclassification. These protections do not eliminate harms if sandbox exposure proves production-like."},"scalability":{"score":3,"rationale":"A repeatable classification and safeguard framework could extend across experiments, but scaling may induce review congestion, inconsistent risk classification, preferential access, and context-specific compliance work."}},"score_confidence":"MODERATE","costs":{"first_evidence":{"band_2026_usd":"10K_TO_50K","scope":"A bounded retrospective and shadow-review study within one business unit, comparing approximately 20–40 pre-matched proposed experiments that entered the ordinary pathway, without launching any experiment.","confidence":"LOW","assumptions":["Relevant proposal, review, abandonment, delay, readiness, sponsorship, integration, and risk records are accessible.","Internal analysts and reviewers can perform the study without new regulated-data infrastructure.","The step includes protocol design, record coding, comparison construction, reviewer time, and a decision memorandum."]},"initial_deployment_startup":{"band_2026_usd":"50K_TO_250K","scope":"Design and prepare a one-business-unit experimental tier for at most ten experiments, including governance, eligibility rules, templates, isolation patterns, logging, training, legal and privacy review, and evaluation setup.","confidence":"LOW","assumptions":["Existing identity, logging, testing, and isolated-environment capabilities can be reused.","Eligible experiments use synthetic or minimized data and avoid production and safety-critical workflows.","No major bespoke integration or new certification is required."]},"operational_launch":{"band_2026_usd":"50K_TO_250K","scope":"Operate the bounded ninety-day, at-most-ten-experiment program, including admissions, multidisciplinary review, monitoring, incident response readiness, applicant support, comparison tracking, and final evaluation.","confidence":"LOW","assumptions":["Experiment-specific engineering is limited and primarily borne within existing sponsor teams.","No material incident triggers a complex investigation or remediation.","The organization already has personnel authorized to conduct security, privacy, procurement, legal, and business review."]},"annual_recurring":{"band_2026_usd":"250K_TO_1M","scope":"Maintain a continuing single-organization program across multiple admission cycles, including program staff, recurring reviews, platform administration, monitoring, audits, incident readiness, equity checks, and outcome evaluation.","confidence":"LOW","assumptions":["The program expands beyond the initial ten cases but remains bounded to low-risk experiments.","Existing sandbox and governance infrastructure remains reusable.","The range excludes production deployment costs for successful products."]}},"research_burden":"MODERATE","earliest_credible_horizon":"3_TO_12_MONTHS","pipeline_gates":{"recognizable_externally_supportable_problem":{"status":"YES","reason":"The candidate defines an observable organizational problem—pre-matched experiments abandoned or delayed at production-grade gates—and identifies records that could support or falsify it. Its actual prevalence and causal importance are not established."},"identifiable_adopter_or_authorizer":{"status":"YES","reason":"Business-unit sponsors and formally delegated procurement, security, privacy, legal, compliance, and business owners are explicitly identified as the joint authorizers of the experimental tier."},"distinct_testable_incremental_claim":{"status":"YES","reason":"The proposal claims that a safeguarded experimental tier will improve launch time and completion relative to comparable ordinary-path cases while satisfying separately declared safety, rights, equity, workload, and evidence-quality thresholds."},"bounded_next_evidence_step":{"status":"YES","reason":"The candidate supplies measurable falsifiers and permits a non-deployment retrospective and shadow-review comparison confined to one business unit and a limited set of pre-matched proposals."},"no_unresolved_safety_or_authority_stop":{"status":"YES","reason":"For evidence gathering without live deployment, no unresolved stop is apparent. Any later pilot remains contingent on joint delegated approval, isolatable exposure, statutory and contractual compliance, explicit exclusions, incident halts, and expiry."},"implementation_cost_scope_and_range":{"status":"UNCERTAIN","reason":"The candidate bounds duration, admissions, and safeguards but provides no staffing, infrastructure, data-access, compliance-effort, or partner-cost evidence; the broad assessment bands therefore depend on unverified assumptions."}},"blocking_evidence":["No evidence establishes that production-grade requirements materially predict abandonment or delay after accounting for product readiness, sponsor commitment, integration needs, and genuine risk.","No evidence shows that enough proposed experiments can be isolated so their exposure is materially below production exposure.","No evidence establishes reviewer willingness, delegated authority in a target organization, or sustainable reviewer workload.","Prior art is unsearched, so distinctiveness relative to existing sandboxes, fast tracks, and risk-tiered pilot pathways is unknown.","The availability and quality of comparable historical cases and process records are unknown."],"next_evidence_step":"In one candidate business unit, predeclare and conduct a non-live retrospective plus blinded shadow review of approximately 20–40 pre-matched startup proposals. Compare ordinary-path abandonment, delay, and evidence generation across proposals classified as sandbox-eligible versus ineligible, adjusting for readiness, sponsor commitment, integration needs, and genuine risk. Falsify the opportunity if production-grade requirements do not materially predict abandonment or delay, nearly all controls remain necessary at sandbox scale, reviewer agreement on eligibility is poor, or too few cases are safely isolatable.","research_questions":["Among pre-matched proposals, which specific production-grade requirements independently predict delay or abandonment after accounting for readiness, sponsorship, integration, and genuine risk?","What fraction of proposals can be isolated using synthetic or minimized data, scoped credentials, and non-production workflows without retaining production-like harms?","Can independent reviewers classify sandbox eligibility consistently, and what review effort does classification require?","Do rejected or abandoned proposals differ systematically in product value, security maturity, sponsor commitment, or integration readiness?","What safety, rights, equity, reviewer-load, and evidence-quality thresholds would joint authorizers require before permitting a live pilot?","What existing sandbox, procurement fast-track, accelerator, or risk-tiered vendor mechanisms overlap with the proposed composition?","Would access rules reduce or reinforce advantages held by applicants with strong internal sponsors?","What infrastructure, staffing, compliance, and incident-readiness resources would the target organization actually require?"] ,"recommendation":"VALIDATE_PROBLEM_FIRST","uncertainty_constraints":["Closed-book assessment with no external validation of prevalence, demand, effect size, prior art, market size, realized impact, or exact cost.","Scores assess the sealed proposal as written and do not establish that the approval wedge is binding in any target organization.","Cost bands are resource-equivalent planning ranges based only on the candidate’s bounded scope and stated safeguards.","A live sandbox is not authorized by this assessment; the next evidence step is non-live and must precede deployment consideration.","The opportunity weakens materially if low-risk exposure cannot be separated from production-like privacy, cybersecurity, reputational, accessibility, or decision harms."],"closed_book_prior_art_boundary":"Prior art is explicitly unsearched. This assessment makes no claim that risk-tiered startup sandboxes, procurement fast tracks, or the stated safeguard composition are novel, rare, or absent from current practice."}